분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2018-10-26 06:31:43 , Hit : 400
 Expanding the reach of gene editing with a new CRISPR enzyme

https://www.fiercebiotech.com/research/expanding-reach-crispr-a-new-enzyme?fbclid=IwAR3UCDadKqdyOTPpVafDhARVuV7FJ3y-cdxqoe1Fn68J2oB0w3U20ycdqPo

FiercePharma

by Angus Liu | Oct 24, 2018 2:00pm

Researchers at MIT have identified a Cas9 enzyme that can help CRISPR target many more disease-specific mutations.

The CRISPR-Cas9 gene editing system has been widely studied because of its potential therapeutic applications, but limitations in the number of locations on the genome it can target remain a major drawback. Now scientists at the Massachusetts Institute of Technology have identified a new Cas9 enzyme that they say can help CRISPR reach more gene mutations.

CRISPR needs a "protospacer adjacent motif (PAM) sequence" to recognize a particular target on DNA for cutting. Without that PAM, no editing can occur. However, the widely used Cas9 enzyme, Streptococcus pyogenes Cas 9 (SpCas9), only recognizes nucleotides that are followed by two G nucleotides as its PAM. That significantly limits the number of locations it can target to about 9.9% of genomic sites, according to the MIT researchers.

Cas9s have been engineered to identify different PAMs, but the MIT team wanted to identify one tool that could cover a wider range of loci by itself. They found one in Streptococcus canis (ScCas9), which can target almost half of the locations on the genome, they reported in the Science Advances.

Team leader Joseph Jacobson compared CRISPR to a postal system. Previous Cas9 systems only allowed researchers to go to a ZIP code that ends in a zero, he explained. “It is very accurate and specific, but it limits you greatly in the number of locations you can go to,” he said in a statement.

Using computational algorithms, the researchers scanned bacterial sequences to find enzymes with less restrictive Pam requirements and then built synthetic versions of the candidate CRISPRs. They went on to evaluate the performance of all the candidates to narrow down the choices.

ScCas9 stood out as the most successful enzyme. It's almost identical to SpCas9 but with the ability to target more DNA sequences. In fact, rather than requiring two G nucleobases as its PAM, the new enzyme needs only one.

The search for better enzymes to perfect CRISPR's precision is a priority in the gene-editing world. A study by scientists at the University of Texas at Austin recently proposed replacing Cas9 with Cas12a to avoid toxic off-target effects, for example. And researchers at the Institute of Bioorganic Chemistry in Poland suggested using a Cas9 “nickase” enzyme that cuts only one strand of DNA instead of two.

In addition to reaching more disease-specific locations, the MIT scientists hope their new CRISPR tool can boost an even more precise variety of gene editing called base editing. While some diseases can be treated by simply knocking out the entire gene of around 1,000 bases, others, such as sickle cell anemia, are caused by the mutation of a single base, Jacobson explained. Therefore, instead of looking at hitting any one of various locations on a gene, “[y]ou need to be able to go to that very exact location, put your piece of CRISPR machinery right next to it, and then with a base editor […] go in and repair or change the base,” he said.

Jacobson and his teammates are now using their technology to identify other enzymes that could expand CRISPR’s targeting range even further.







1107   Dynamic view of the MS genome  이성욱 2010/05/01 2718
1106   Early-Earth cells modeled to show how first life forms might have packaged RNA  이성욱 2012/10/16 2516
1105   Editas Expands CRISPR Capabilities through New Technology Licensing  이성욱 2016/12/22 821
1104   Efficient Process Using microRNA Converts Human Skin Cells Into Neurons  이성욱 2011/07/19 2238
1103   Electronics Giant Samsung Makes First Big Biotech Play  이성욱 2013/02/22 3166
1102   EMA panel recommends approval of DAA regimen for patients with HCV  이성욱 2014/11/26 1284
1101   Embryonic stem cells improve vision for two women  이성욱 2012/01/25 2337
1100   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 782
1099   Engineered Viruses Selectively Kill Cancer Cells  이성욱 2011/09/02 2445
1098   Engineering Better Immune Cells  이성욱 2010/05/06 2700
1097   EU, 2번째 유전자치료제 ‘스트림벨리스’ 승인  이성욱 2016/09/05 1147
1096   European regulators back first gene therapy drug  이성욱 2012/07/24 2669
1095   Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice  이성욱 2019/01/15 780
  Expanding the reach of gene editing with a new CRISPR enzyme  이성욱 2018/10/26 400
1093   Experimental Hepatitis C Drug Shows Promise for Preventing Recurrence in Liver Transplant Patients  이성욱 2013/11/06 2135
1092   Experts find rogue stem cells in liver cancer  이성욱 2011/07/09 2571
1091   Fathers Can Pass Mitochondrial DNA to Children  이성욱 2018/12/26 799
1090   FDA approves 9-valent HPV vaccine for certain cancers  이성욱 2014/12/12 1142
1089   FDA Approves First Gene Therapy for Inherited Disease  이성욱 2017/12/22 512
1088   FDA Approves Gilead CAR-T Therapy Yescarta, Plans Regenerative Medicine Policy 'Soon'  이성욱 2017/10/20 609

[1][2][3][4][5][6][7][8] 9 [10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN